lunedì, 4 maggio 2026

Notizie AIOM – anno XVII

9 Settembre 2019

First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium

In metastatic renal-cell carcinoma (mRCC), recent data have shown efficacy of first-line ipilimumab and nivolumab (ipi-nivo) as well as immuno-oncology (IO)/vascular endothelial growth factor (VEGF) inhibitor combinations. Comparative data between these strategies are limited. ...
Leggi tutto

9 Settembre 2019

6 settembre 2019 – Comunicazione EMA su Ingenolo mebutato (LEO)

9 Settembre 2019

6 settembre 2019 – Aggiornamento sulla carenza del farmaco Bleomicina (Sanofi)

9 Settembre 2019

6 settembre 2019 – Chiusura Registro di monitoraggio Cabozantinib (Ipsen) (RCC)

9 Settembre 2019

6 settembre 2019 – Modifica Registro Pertuzumab (Roche) – Utilizzo dei biosimilari di trastuzumab in associazione a pertuzumab nel carcinoma mammario Her2 positivo metastatico

9 Settembre 2019

6 settembre 2019 – Chiarimento utilizzo dei medicinali equivalenti e biosimilari

9 Settembre 2019

FDA Grants Capmatinib Breakthrough Designation in Frontline METex14-Mutated NSCLC

Sep 6, 2019 - The FDA has granted a breakthrough therapy designation to capmatinib (INC280) as a first-line treatment for patients with MET exon14 skipping (METex14)-mutated non-small cell lung cancer (NSCLC). The decision is based on primary findings from the phase II GEOMETRY ...
Leggi tutto

6 Settembre 2019

USPSTF Releases Final Recommendation on Treatments for Reducing Breast Cancer Risk

Sep 4, 2019 - Risk-reducing therapies, such as tamoxifen, raloxifene, or aromatase inhibitors, should be administered to women who are at an increased risk for breast cancer and at a low risk for adverse events (AEs) associated with these medications, according to an updated ...
Leggi tutto

6 Settembre 2019

ASTRO Guideline on Use of Radiation Therapy for Patients With Pancreatic Cancer

Sep 5, 2019 - A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to treat patients diagnosed with pancreatic cancer, including when radiation treatments are appropriate, as well as the ...
Leggi tutto

6 Settembre 2019

ASCO and MASCC/ISOO Release a Clinical Practice Guideline on Medication-Related Osteonecrosis of the Jaw

Sep 5, 2019 - ASCO and the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) have published a clinical practice guideline on medication-related osteonecrosis of the jaw in the Journal of Clinical Oncology. The guideline ...
Leggi tutto